Chicago startup Evozyne has raised $81 million following a generative AI collaboration with Nvidia announced earlier this year.
Evozyne Announces $81 Million Financing Round to Advance Generative AI for Therapeutic Discovery and Drug Development
CHICAGO, Sept. 20, 2022 /PRNewswire/ -- Evozyne today announced Janne Kerovuo, PhD, as its senior vice president of research and development, a newly created position at the Chicago-based biology engineering company.